Masaaki Fukuda

1.4k total citations
52 papers, 1.1k citations indexed

About

Masaaki Fukuda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Masaaki Fukuda has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Masaaki Fukuda's work include Lung Cancer Research Studies (20 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer therapeutics and mechanisms (9 papers). Masaaki Fukuda is often cited by papers focused on Lung Cancer Research Studies (20 papers), Lung Cancer Treatments and Mutations (17 papers) and Cancer therapeutics and mechanisms (9 papers). Masaaki Fukuda collaborates with scholars based in Japan, United States and United Kingdom. Masaaki Fukuda's co-authors include Yasutsuna Sasaki, Tomohide Tamura, Hiroshi Soda, Tetsu Shinkai, Kenji Eguchi, Shigeru Kohno, Yoshifumi Soejima, Yuichiro Ohe, Satoshi Watanabe and Masashi Kodama and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Masaaki Fukuda

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaaki Fukuda Japan 19 535 408 191 113 83 52 1.1k
Yao-Bin Liu China 17 262 0.5× 241 0.6× 179 0.9× 21 0.2× 107 1.3× 34 937
Hiroki Koyama Japan 23 552 1.0× 256 0.6× 243 1.3× 36 0.3× 53 0.6× 98 2.0k
Xiaodong He China 25 297 0.6× 237 0.6× 309 1.6× 107 0.9× 31 0.4× 106 1.5k
Daisuke Kubota Japan 25 331 0.6× 506 1.2× 372 1.9× 270 2.4× 19 0.2× 123 1.8k
Yutao Gong United States 12 447 0.8× 267 0.7× 175 0.9× 18 0.2× 22 0.3× 35 1.1k
Angela Jones United States 19 236 0.4× 89 0.2× 531 2.8× 40 0.4× 52 0.6× 51 1.5k
Hiroaki Arakawa Japan 29 130 0.2× 1.6k 4.0× 92 0.5× 64 0.6× 94 1.1× 87 2.3k
Bente Lund Denmark 16 452 0.8× 99 0.2× 134 0.7× 36 0.3× 55 0.7× 44 834
Xiaoping Yao China 18 145 0.3× 58 0.1× 155 0.8× 44 0.4× 215 2.6× 39 828
Xiaoming Yang United States 19 143 0.3× 170 0.4× 364 1.9× 21 0.2× 18 0.2× 113 1.3k

Countries citing papers authored by Masaaki Fukuda

Since Specialization
Citations

This map shows the geographic impact of Masaaki Fukuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Fukuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Fukuda more than expected).

Fields of papers citing papers by Masaaki Fukuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Fukuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Fukuda. The network helps show where Masaaki Fukuda may publish in the future.

Co-authorship network of co-authors of Masaaki Fukuda

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Fukuda. A scholar is included among the top collaborators of Masaaki Fukuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Fukuda. Masaaki Fukuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikeda, Takaya, Shinnosuke Takemoto, Hirokazu Taniguchi, et al.. (2020). Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study. Thoracic Cancer. 11(7). 1972–1978. 5 indexed citations
2.
Takemoto, Shinnosuke, Minoru Fukuda, Minoru Fukuda, et al.. (2019). Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study. Thoracic Cancer. 11(2). 389–393. 3 indexed citations
3.
Ohue, Yoshihiro, Koji Kurose, Takahiro Karasaki, et al.. (2019). Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC. Journal of Thoracic Oncology. 14(12). 2071–2083. 34 indexed citations
4.
Kaku, Norihito, Kohji Hashiguchi, Norihiko Akamatsu, et al.. (2018). Evaluation of FilmArray respiratory panel multiplex polymerase chain reaction assay for detection of pathogens in adult outpatients with acute respiratory tract infection. Journal of Infection and Chemotherapy. 24(9). 734–738. 20 indexed citations
5.
Shimada, Midori, Minoru Fukuda, Takeshi Kitazaki, et al.. (2016). Primary Mediastinal Large B-cell Lymphoma Exhibiting Endobronchial Involvement. Internal Medicine. 55(21). 3147–3150.
6.
Kawaguchi, Tomoya, Masahiko Ando, Kazuhiro Asami, et al.. (2014). Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA). Journal of Clinical Oncology. 32(18). 1902–1908. 197 indexed citations
7.
8.
Nakamura, Yoichi, Hiroshi Soda, Mikio Oka, et al.. (2010). Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia. Journal of Thoracic Oncology. 6(1). 121–127. 27 indexed citations
9.
Fukuda, Minoru, Yoichi Nakamura, Takashi Kasai, et al.. (2009). A Phase I Study of Amrubicin and Carboplatin for Previously Untreated Patients with Extensive-Disease Small Cell Lung Cancer. Journal of Thoracic Oncology. 4(6). 741–745. 11 indexed citations
10.
Akamine, Shinji, Yoichi Nakamura, Tadayuki Oka, et al.. (2008). Induction Chemotherapy with Cisplatin, Vinorelbine, and Mitomycin-C Followed by Surgery for Patients with Pathologic N2 Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 9(1). 44–50. 1 indexed citations
11.
Fukuda, Minoru, Minoru Fukuda, Hiroshi Soda, et al.. (2007). Irinotecan and cisplatin with concurrent split‐course radiotherapy in locally advanced nonsmall‐cell lung cancer. Cancer. 110(3). 606–613. 12 indexed citations
12.
Nakano, Hirofumi, Hiroshi Soda, Masaaki Fukuda, Shigeru Kohno, & Kazuhiro Tsukamoto. (2006). Methylation status of BCRP detected by methylation-specific PCR is inversely correlated with its expression and drug resistance in vitro and in patients with cancers. Cancer Research. 66. 1–1. 29 indexed citations
13.
Xu, Hongde, et al.. (2006). Parentally imprinted allele typing at a short tandem repeat locus in intron 1a of imprinted gene KCNQ1. Legal Medicine. 8(3). 139–143. 4 indexed citations
14.
Oka, Mikio, Minoru Fukuda, Seiji Nagashima, et al.. (2001). Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 48(6). 446–450. 11 indexed citations
15.
Sakamoto, Akira, Minoru Fukuda, Hiroshi Takatani, et al.. (1997). Expression of Glutathione S-transferase-pi (GST-pi) and Metallothionein (MT) in Lung Cancer.. Haigan. 37(2). 135–141. 1 indexed citations
16.
Soda, Hiroshi, Oka M, Masaaki Fukuda, et al.. (1996). Optimal schedule for administering granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 38(1). 9–12. 16 indexed citations
17.
Fukuda, Masaaki, Tetsu Shinkai, Kenji Eguchi, et al.. (1990). Phase II study of (glycolate-O,O′) diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 26(6). 393–396. 74 indexed citations
18.
Eguchi, Kenji, Tetsu Shinkai, Yasutsuna Sasaki, et al.. (1990). Subcutaneous Administration of Recombinant Human Granulocyte Colony‐stimulating Factor (KRN8601) in Intensive Chemotherapy for Patients with Advanced Lung Cancer. Japanese Journal of Cancer Research. 81(11). 1168–1174. 21 indexed citations
19.
Fukuda, Masaaki, et al.. (1986). Protein and nucleic acid changes during early developmental stages of cresthead flounder.. NIPPON SUISAN GAKKAISHI. 52(6). 951–955. 15 indexed citations
20.
Nishizawa, Satoshi, et al.. (1954). PHOTOGRAPHIC STUDY OF SUSPENDED MATTER AND PLANKTON IN THE SEA. Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University). 5(1). 36–40. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao-Bin Liu Breakdown of academic impact, for papers by Hiroki Koyama Breakdown of academic impact, for papers by Xiaodong He Breakdown of academic impact, for papers by Daisuke Kubota Breakdown of academic impact, for papers by Yutao Gong Breakdown of academic impact, for papers by Angela Jones Breakdown of academic impact, for papers by Hiroaki Arakawa Breakdown of academic impact, for papers by Bente Lund Breakdown of academic impact, for papers by Xiaoping Yao Breakdown of academic impact, for papers by Xiaoming Yang
Rankless by CCL
2026